Home Commercialization
Product Applications Print E-mail

Biosceptre's platform technology is protected by patents and patent applications for the detection and treatment of cancer with the use of targeted antibodies. The novel marker is highly specific, is found in approximately 90% of all cancer types, and requires no new technology for the commercialization of diagnostic or therapeutic products.

With the initial product focus being the topical therapeutic application of its IP, the Company has shown significant positive results in the programs undertaken to date. Biosceptre’s technology has a broad range of potential product applications including:

  • topical therapeutics
  • systemic therapeutics
  • in vitro diagnostics (IVDs) - Immunohistochemistry (IHC)
  • in vivo imaging diagnostics
  • animal health
  • vaccines
 

Biosceptre Poll

How important is cancer research to you?